Eiichi Kaga

Director at Rakuten Medical

Capital raised by Rakuten Medical

$113.4M+$111.5M latest round

3 Form D filings · first filed Dec 2024 · San Diego, CA

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 3
TEAM ON FILE: 3
FOUNDED: —
30D INTEREST: —

Career

1 company on file

Rakuten MedicalBiotech · San Diego, CAsince Dec 2024

Director

Listed on Rakuten Medical's Form D filings

Company filings

via EDGAR · Form D for Rakuten Medical3

DateCompanyFormAmountRole on filing

Jul 11, 2025Rakuten MedicalForm D+$111.5M—

Form DJul 11, 2025 · Rakuten Medical+$111.5Mnot a signer

Dec 12, 2024Rakuten MedicalForm D/A+$1.9M—

Form D/ADec 12, 2024 · Rakuten Medical+$1.9Mnot a signer

Dec 12, 2024Rakuten MedicalForm D+$1.4M—

Form DDec 12, 2024 · Rakuten Medical+$1.4Mnot a signer

Overview

Last filing Jul 11, 2025

Eiichi Kaga is on file as Director at Rakuten Medical in San Diego, CA. Rakuten Medical has 3 Form D filings on record, $113.4M raised in total.

Teammates

Rakuten Medical · 2

Suzane SanExecutive Officer Tiffany PiecewiczSecretarySigner

Products

Rakuten Medical · 1

ASP-1929Photoimmunotherapy

ASP-1929 is a pioneering cancer treatment under development that employs Rakuten Medical's photoimmunotherapy technology. This approach uses antibodies that specifically bind to cancer cells and are activated by an external light source, enhancing treatment precision.